Page 16 - Query Get News Today

Novartis temporarily suspended production at two of its radioligand therapy production sites.Novartis took the voluntary action “out of an abundance of caution as a result of potential quality issues” identified in the manufacturing process, a company-issued press release stated.

Warts, hypogammaglobulinemia, infections and myelokathexis — or WHIM — syndrome is a rare but important primary immunodeficiency that leaves some patients susceptible to life-threatening infections as well as to cancer. Healio spoke with Teresa Kathleen Tarrant, MD, associate professor in rheumatology and immunology at Duke University School of Medicine, to find out more about the

HHS has announced the launch of the Maternal Mental Health Hotline, a national, confidential, toll-free service for new and expecting mothers who are experiencing mental health challenges. The hotline will launch May 8 — Mother’s Day — with counselors available to provide mental health support.

Daily supplementation with vitamin D3 and omega-3 fatty acids, in conjunction with a strength exercise program, may reduce the risk for cancer in adults aged 70 years and older, according to results of a randomized controlled trial. “Based on our findings, with the triple combination, we would need to treat 35 persons (95% CI, 26-137) in order to prevent one incident case of cancer at 3

Different age-specific patterns defined the relationships between early daycare, severe airway infection, preterm birth and atopy-related diseases in childhood, according to a study published in Pediatric Allergy and Immunology. These differences could be used to help identify strategies to prevent or delay atopic diseases, Tadao Nagasaki, of the department of respiratory medicine at the Graduate

The FDA granted breakthrough device designation and permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease. Developed by Fujirebio Diagnostics, the Lumipulse G β-Amyloid Ratio test is intended for adults, aged 55 years and older, presenting with cognitive impairment who are being evaluated for AD and other

Xcardia Innovation Ltd., following the February FDA 510(k) clearance of its device for cardiac pacemaker and defibrillator lead extraction, announced the first-in-human use of the new device. According to a company press release, the new device (Xtractor) is designed with advanced controls, incorporating motor-assisted activation, steering capability, pedal activation and an advanced tip

The FDA cleared a new electrophysiology recording technology designed to improve signal acquisition and accuracy of electrogram interpretation in the diagnosis and treatment of complex atrial arrythmias, CathVision announced.The ECGenius EP Recording System includes EP recording technology and a proprietary hardware amplifier to acquire high-fidelity, low-noise, cardiac electrograms to help

Through 12 months, psilocybin-assisted treatment showed to be safe and effective for major depressive disorder, researchers reported in the Journal of Psychopharmacology. Natalie Gukasyan, MD, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University in Baltimore, and colleagues conducted a randomized, waiting-list controlled study of 24 patients between the

TecTraum Inc. announced complete enrollment status for a clinical trial evaluating its pro2cool device, a noninvasive hypothermic therapy system for treating concussions. The device, designed to decrease the severity of concussion symptoms, provides localized cooling for the head and neck to lower blood temperature before reaching the brain, the company stated in a press release.